Cash Flow from Financial Activities: The net amount of cash transactions used in funding activities.
Lisata Therapeutics, Inc. (LSTA) had Cash Flow from Financial Activities of $-0.21M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$1.00M |
|
$-19.98M |
|
-- |
|
$1.00M |
|
$23.41M |
|
$-22.41M |
|
$1.63M |
|
$-20.78M |
|
$-20.78M |
|
$-19.98M |
|
$-19.98M |
|
$-19.98M |
|
$-19.98M |
|
$-22.41M |
|
$-22.69M |
|
8.33M |
|
8.33M |
|
$-2.40 |
|
$-2.40 |
|
| Balance Sheet Financials | |
$34.58M |
|
$0.07M |
|
$0.42M |
|
$35.00M |
|
$5.61M |
|
-- |
|
$0.07M |
|
$5.68M |
|
$29.32M |
|
$29.12M |
|
$29.32M |
|
8.41M |
|
| Cash Flow Statement Financials | |
$-19.36M |
|
$13.23M |
|
|
Cash Flow from Financial Activities |
$-0.21M |
$22.59M |
|
$16.21M |
|
$-6.38M |
|
$1.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-2240.90% |
|
-2240.90% |
|
-2269.00% |
|
-2078.30% |
|
-1998.50% |
|
$-19.36M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
1.11 |
|
328.50 |
|
-68.17% |
|
-68.62% |
|
-57.10% |
|
-68.17% |
|
$3.49 |
|
$-2.32 |
|
$-2.32 |
|